HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berman, P. A. Articles by Human, L. Search for Related Content PubMed PubMed Citation Articles by Berman, P. A. Articles by Human, L. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 12, 6562-6568, 04, 1990

Regulation of 5-phosphoribosyl 1-pyrophosphate and of hypoxanthine uptake and release in human erythrocytes by oxypurine cycling

PA Berman and L Human
Department of Chemical Pathology, University of Cape Town Medical School, Observatory, South Africa.

Uptake and release of purines by red blood cells has been shown to be markedly sensitive to changes in pH, inorganic phosphate (Pi), and oxygen concentration (Berman, P., Black, D., Human, L., and Harley, E. (1988) J. Clin. Invest. 82, 980-986). The mechanism of this regulation has been further studied. We have shown that incubation of red cells in medium containing xanthine oxidase rapidly and completely depletes intracellular hypoxanthine and causes accumulation of 5-phosphoribosyl 1-pyrophosphate (PRPP) at physiological Pi concentrations. Hypoxanthine release from intracellular IMP is strictly dependent on PRPP depletion, induced by either alkalinizing the cells or by adding excess adenine. Xanthine oxidase abolishes this dependence. Oxygen depletion enhances adenine uptake and prevents hypoxanthine release. The results suggest that hypoxanthine release is governed by PRPP-dependent recycling of hypoxanthine to IMP. We propose that PRPP accumulation in red cells is regulated by a substrate cycle, comprising hypoxanthine, IMP, and inosine. Cycle flux is controlled by Pi inhibition and 2,3- bisphosphoglycerate activation of purine-5'-nucleotidase, which converts IMP to inosine. Oxypurine cycling may account for the sensitive control of purine uptake and release by changes in pH and oxygen tension that occur physiologically.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Pettersson, M. E. Schrumpf, S. J. Raffel, S. F. Porcella, C. Guyard, K. Lawrence, F. C. Gherardini, and T. G. Schwan Purine Salvage Pathways among Borrelia Species Infect. Immun., August 1, 2007; 75(8): 3877 - 3884. [Abstract] [Full Text] [PDF]

				E. M. Slominska, E. A. Carrey, H. Foks, C. Orlewska, E. Wieczerzak, P. Sowinski, M. H. Yacoub, A. M. Marinaki, H. A. Simmonds, and R. T. Smolenski A Novel Nucleotide Found in Human Erythrocytes, 4-Pyridone-3-carboxamide-1-beta-D-ribonucleoside Triphosphate J. Biol. Chem., October 27, 2006; 281(43): 32057 - 32064. [Abstract] [Full Text] [PDF]

				J. Hariharan, R. Rane, K. Ayyanathan, Philomena, V. P. Kumar, D. Prahlad, and S. Datta Mechanism-Based Inhibitors: Development of a High Throughput Coupled Enzyme Assay to Screen for Novel Antimalarials J Biomol Screen, August 1, 1999; 4(4): 187 - 192. [Abstract] [PDF]